Foundation News
Team KACF Rides Again: 6th Year Participating in Cycle for Survival
Cycle for Survival, which ranks as the fastest growing athletic fundraiser in the country, attracted 31,000 participants in 16 cities across the United States and internationally. Equinox Clubs, which hosts the rides propelled Cycle for Survival to reach an incredible $200 million! It takes a movement powered by a fierce and dedicated community to reach…
Read More2018 A Record-Breaking Year!
Our 25th Anniversary Gala last April 21st was another amazing A Night to Remember. Hosted by Barbara Carr, Dave Marsh and Sasha Carr, Kristen’s legacy was front and center as the evening was shared with many longtime supporters and new friends. Over 400 guests dined on the always exceptional cuisines from Tribeca Grill, NOBU, Batard,…
Read MoreSarcoma Research Led by Aimee Crago, MD, PhD
Ongoing support from the Kristen Ann Carr Fund (KACF) to Memorial Sloan Kettering Cancer Center (MSK) is funding critical research in the laboratory of Aimee Crago, MD, PhD, a surgeon specializing in soft tissue sarcomas. Surgical removal of well- and de-differentiated liposarcomas is almost universally followed by an aggressive recurrence of these cancers. Systemic treatments,…
Read MoreThe Kristen Ann Carr Fund welcomes the 2017/2018 Surgical Fellow, Edmund (Ned) King Bartlett, MD
Dr. Bartlett will gain extensive clinical experience at MSK, where he’ll study recurrence patterns in patients with liposarcomas in their arms or legs. Liposarcomas are the most common type of sarcoma (approximately 20% of all such tumors). There are also several sub-types: well difrerentiated, dediferentiated, pleomorphc, myxoid, round cell. The clinical significance of these subtypes…
Read MoreFunding from The Kristen Ann Carr Fund Propels the Work of World-Renowned Pathologist and Director of Bone and Soft Tissue Pathology at Memorial Sloan Kettering Cancer Center, Cristina Antonescu, MD
Dr. Antonescu’s research centers on the deep molecular characterization of rare sarcomas that strike children and young adults. The essence of precision medicine, these critical data point to the inner workings of a tumor, and are used to guide treatment decisions. The Fund is supporting Dr. Antonescu’s study of tumors that contain “simple” genetic abnormalities,…
Read MoreLiposarcoma and other ‘orphan diseases’ warrant research and attention
The LA Times recently published an article by liposarcoma specialist Dr. William W Tseng. In it, he speaks about what drives those who specialize in treating and researching “orphan diseases” such as sarcoma. Click HERE to read more.
Read MoreJoin KACF to Ride in Cycle for Survival Again!
We are excited to let you know the Kristen Ann Carr Fund will be riding as a team for Cycle for Survival on Sunday February 12th at Equinox in Greenwich, CT. We have 16 people riding including Ilyse and Paul Lesser, Nina Mohr and Tristine Skyler. Last year we raised over $20,000 and this year we are…
Read MoreVideo Interview with Dr. George Demetri
This short video interview with Dr. George Demetri reaffirms why our work with sarcoma is so significant in understanding and ultimately conquering other cancer types: http://bit.ly/29Owmua
Read MoreKACF Rides in Cycle for Survival Again!
We are so happy to share that the The Kristen Ann Carr Fund will be riding as a team again for Cycle for Survival on February 21st at Equinox in Greenwich, CT. We have 16 people riding including Ilyse, Paul, and Courtney Lesser, James and Katie Dunning, Ryan and Lauren Fisher, and Tristine Skyler. Last year we raised over $10,000 and this year we are…
Read MoreHow Rare is Liposarcoma?
The Globe and Mail covered a story recently on Mayor Rob Ford’s recent liposarcoma tumor diagnosis. The article takes a deeper dive into liposarcoma, using this graph to clarify just how rare liposarcoma is compare to various other types of cancers. Click HERE to read more.
Read More